Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells

BACKGROUND: Type 1 diabetes (T1D) is a multifactorial autoimmune disorder where pancreatic beta cells are lost before the clinical manifestations of the disease. Administration of mesenchymal stem cells (MSCs) or MSCs differentiated into insulin-producing cells (IPCs) have yielded limited success wh...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Anshu, Rani, Rajni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508489/
https://www.ncbi.nlm.nih.gov/pubmed/28701182
http://dx.doi.org/10.1186/s13287-017-0615-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508489/
https://www.ncbi.nlm.nih.gov/pubmed/28701182
http://dx.doi.org/10.1186/s13287-017-0615-1

Ejemplares similares